Validation of an ultra-fast UPLC-UV method for the separation of antituberculosis tablets
✍ Scribed by Dao T.-T. Nguyen; Davy Guillarme; Serge Rudaz; Jean-Luc Veuthey
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 832 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A simple method using ultra performance LC (UPLC) coupled with UV detection was developed and validated for the determination of antituberculosis drugs in combined dosage form, i. e. isoniazid (ISN), pyrazinamide (PYR) and rifampicin (RIF). Drugs were separated on a short column (2.1 mm×50 mm) packed with 1.7 μm particles, using an elution gradient procedure. At 30°C, less than 2 min was necessary for the complete separation of the three antituberculosis drugs, while the original USP method was performed in 15 min. Further improvements were obtained with the combination of UPLC and high temperature (up to 90°C), namely HT‐UPLC, which allows the application of higher mobile phase flow rates. Therefore, the separation of ISN, PYR and RIF was performed in less than 1 min. After validation (selectivity, trueness, precision and accuracy), both methods (UPLC and HT‐UPLC) have proven suitable for the routine quality control analysis of antituberculosis drugs in combined dosage form. Additionally, a large number of samples per day can be analysed due to the short analysis times.
📜 SIMILAR VOLUMES
## Abstract Using a one‐step preparative hydrostatic countercurrent chromatography method, the fragrant massoia lactones were purified from the crude massoia bark oil, in less than 3 h. The fractionation was performed with the biphasic solvent system __c__‐hexane–methanol–water (10:9:1, v/v/v), lea
## Abstract (+)‐Pinoresinol 4,4′‐di‐__O__‐β__‐__D‐glucopyranoside ((+)‐PDG) is one of the major lignans with various pharmacological activities which could be isolated from Duzhong and other plant species. In this study, a diastereomeric impurity, (−)‐pinoresinol 4,4′‐di‐__O__‐β__‐__D‐glucopyranosi